论文部分内容阅读
原发性骨质疏松症(绝经后及老年性骨质疏松症)[1]是由多种原因引起的一组骨病,在骨质疏松中,骨组织代谢平衡失调是其病理基础,主要表现为骨质吸收的增多、骨量减少,这就使得骨质疏松症患者的骨代谢处于负平衡,即破骨细胞的成熟分化多于成骨细胞的成熟分化。因此,对于骨质疏松的治疗一直以来都是围绕调整骨代谢,纠正骨代谢平衡失调而进行。目前临床上防治骨质疏松症的药物主要
Primary osteoporosis (postmenopausal and senile osteoporosis) [1] is a group of bone diseases caused by a variety of causes. In osteoporosis, imbalanced metabolism of bone tissue is the pathological basis of the disease The performance of increased bone absorption, decreased bone mass, which makes osteoporosis in patients with bone metabolism in a negative balance, that osteoclasts mature differentiation than osteoblastic maturation. Therefore, the treatment of osteoporosis has always been around the adjustment of bone metabolism, bone metabolism to correct imbalances. At present, the main clinical prevention and treatment of osteoporosis drugs